Award
NIH Reporter #5R44AI181154-03
Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)
Recipient
Not Specified
Award Amount
$919,857.00
Ceiling
$919,857.00
Awarded
August 04, 2026
Identifier
5R44AI181154-03
Award for developing a point-of-care molecular diagnostic assay for urinary tract infections with rapid detection and antimicrobial resistance markers, funded by NIH.
Description
This project involves the development of a point-of-care molecular diagnostic for urinary tract infections, focusing on rapid detection and antimicrobial resistance markers. The project aims to expand target panels, optimize assay design, verify analytical performance, and conduct clinical validation. It is funded by NIH and involves collaboration with Brigham & Women’s Hospital.